F/m Emerald Life Sciences Innovation ETF Rating $24.61 -0.21 (-0.84%) As of 03:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsTrendsBuy This Stock F/m Emerald Life Sciences Innovation ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.LFSC Aggregate RatingModerate Buy 2.93Holdings in LFSC have an aggregate rating of Moderate Buy based on 312 analyst ratings issued in the past year covering 30 companies (99.1% of the portfolio).LFSC Aggregate Price Target$24.61High Prediction$24.61Average Prediction$24.61Low Prediction$24.61Holdings in LFSC have an aggregate price target of $24.61 and a range of $24.61 to $24.61 covering 30 companies (99.1% of the portfolio).LFSC Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy14 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by F/m Emerald Life Sciences Innovation ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 30 LFSC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings7.60%BBIOBridgeBio Pharma$44.86-0.6%4.682 of 5 stars2.92$57.42 28.0%13Analyst ForecastInsider TradeHigh Trading Volume7.42%SLNOSoleno Therapeutics$83.25-0.9%4.6465 of 5 stars3.09$107.10 28.6%11High Trading Volume7.05%TMDXTransMedics Group$131.45+1.1%1.3648 of 5 stars2.80$127.33 -3.1%106.23%LIVNLivaNova$45.75-0.1%3.2107 of 5 stars3.00$59.29 29.6%8Positive News5.96%BPMCBlueprint Medicines$128.110.0%1.6752 of 5 stars2.27$128.06 0.0%22Positive NewsHigh Trading Volume5.92%RDNTRadNet$57.12-1.6%3.4987 of 5 stars3.50$69.60 21.8%64.78%INSMInsmed$99.49-2.2%3.9815 of 5 stars3.00$106.80 7.3%17Insider TradeHigh Trading Volume4.75%MMSIMerit Medical Systems$93.50+0.8%4.3395 of 5 stars3.00$109.11 16.7%10Positive NewsHigh Trading Volume4.19%COLLCollegium Pharmaceutical$29.93+0.1%3.941 of 5 stars2.75$43.75 46.2%44.14%ETNB89BIO$9.86-0.9%2.2637 of 5 stars3.00$26.43 168.0%8Positive NewsHigh Trading Volume4.04%RAREUltragenyx Pharmaceutical$36.52-1.6%3.9919 of 5 stars2.93$87.00 138.2%14News CoverageHigh Trading Volume3.96%TVTXTravere Therapeutics$14.77-2.4%3.0084 of 5 stars2.87$32.14 117.6%15High Trading Volume3.52%GHGuardant Health$50.86+1.7%3.4301 of 5 stars3.00$53.76 5.7%213.51%ATECAlphatec$11.08+1.7%4.1818 of 5 stars2.89$17.89 61.5%93.27%MDGLMadrigal Pharmaceuticals$300.75+0.4%3.9069 of 5 stars2.89$420.63 39.9%93.09%WVEWAVE Life Sciences$6.67-5.1%4.4058 of 5 stars2.92$20.50 207.3%12High Trading Volume2.94%AKROAkero Therapeutics$56.19-0.2%3.651 of 5 stars3.00$82.50 46.8%6High Trading Volume2.72%KALVKalVista Pharmaceuticals$11.41-0.8%4.2111 of 5 stars3.13$24.83 117.6%8High Trading Volume2.27%CORTCorcept Therapeutics$73.22-1.5%4.6898 of 5 stars3.00$138.25 88.8%5Positive NewsHigh Trading Volume1.92%ACADACADIA Pharmaceuticals$22.12-0.4%4.6625 of 5 stars2.71$27.88 26.0%17Trending NewsAnalyst Forecast1.66%SYRESpyre Therapeutics$15.22-5.0%1.9404 of 5 stars3.25$53.40 250.9%8High Trading Volume1.47%GMEDGlobus Medical$58.54-0.5%4.9132 of 5 stars2.62$94.00 60.6%131.33%UTHRUnited Therapeutics$284.27+0.1%4.9941 of 5 stars2.69$393.08 38.3%13Positive NewsInsider Trade1.11%NVCRNovoCure$18.00+5.3%3.8944 of 5 stars2.67$32.83 82.4%6Positive NewsAnalyst ForecastHigh Trading Volume0.94%ITGRInteger$122.73+0.7%3.6123 of 5 stars3.00$145.00 18.1%9High Trading Volume0.91%SVRASavara$2.212.5836 of 5 stars2.60$5.60 153.4%5Positive News0.76%OFIXOrthofix Medical$11.09+0.5%3.1987 of 5 stars3.00$21.50 93.9%5Analyst RevisionHigh Trading Volume0.64%CBLLCeriBell$18.90-2.0%2.6744 of 5 stars3.00$32.14 70.1%8Analyst ForecastHigh Trading Volume0.62%BHVNBiohaven$14.10-4.3%3.1462 of 5 stars3.07$58.46 314.6%15High Trading Volume0.35%MURAMural Oncology$2.483.4887 of 5 stars2.60$13.00 424.2%5Positive News This page (NASDAQ:LFSC) was last updated on 6/27/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding F/m Emerald Life Sciences Innovation ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share F/m Emerald Life Sciences Innovation ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
